FDA 510(k)

ADVIA Centaur 红细胞生成素（EPO）测定

K号: K183088 · 2019-08-02

决定日期2019-08-02

产品代码GGT

咨询委员会HE 请注意，由于您只提供了“HE”作为输入，我无法提供完整的翻译。请提供完整的描述或文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

ADVIA Centaur Erythropoietin (EPO) assay is the device name listed in this FDA 510(k) record. The listed applicant is Axis-Shield Diagnostics Limited. It received FDA 510(k) clearance on 2019-08-02 under 510(k) number K183088. The device is classified under product code GGT. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the ADVIA Centaur Erythropoietin (EPO) assay?

ADVIA Centaur Erythropoietin (EPO) assay is a medical device that received FDA 510(k) clearance on 2019-08-02. The listed applicant is Axis-Shield Diagnostics Limited. The 510(k) number is K183088.

When did ADVIA Centaur Erythropoietin (EPO) assay receive FDA 510(k) clearance?

ADVIA Centaur Erythropoietin (EPO) assay received FDA 510(k) clearance on 2019-08-02, under 510(k) number K183088.

Who is the listed applicant for ADVIA Centaur Erythropoietin (EPO) assay?

The FDA 510(k) record lists Axis-Shield Diagnostics Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ADVIA Centaur Erythropoietin (EPO) assay?

The FDA product code for ADVIA Centaur Erythropoietin (EPO) assay is GGT.

列明Axis-Shield Diagnostics Limited为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K182012ADVIA Centaur 降钙素（CALCT）测定 K153551医疗器械监管政策：医疗设备监管规定- ADV坎塔特抗-CCP IgG (aCCP nâ´) 检测试剂包括试剂和校准材料、质量控制材料和曲线材料 nâ´K160757ADVIA Centaur Active-B12 (全反式钴胺素)(AB12) 测定，ADVIA Centaur Active-B12(AB12) 质量控制，以及ADVIA Centaur Active-B12 (AB12) 主曲线材料（MCM）

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。